Apple 因停產智慧手錶型號對 Masimo 提起 250 美元專利訴訟並獲勝

陪審團認定，Masimo 侵犯了蘋果與已不再上市的舊款智慧手錶中的健康技術相關的專利。

A Delaware jury has sided with Apple Inc. (NASDAQ:AAPL) in a patent infringement case against Masimo Corp. (NASDAQ:MASI), awarding the Cupertino company a symbolic $250 in damages.

特拉華州陪審團在針對Masimo Corp.（納斯達克股票代碼：MASI）的專利侵權案中站在蘋果公司（納斯達克股票代碼：AAPL）一邊，判給這家庫比蒂諾公司象徵性的250 美元賠償金。

What Happened: The jury decided that Masimo infringed on Apple’s patents related to health technology in older smartwatch models that are no longer on the market, reported Reuters.

發生的事情：根據路透社報道，陪審團裁定 Masimo 侵犯了蘋果與已不再上市的舊款智慧手錶中的健康技術相關的專利。

The lawsuit, initiated by Apple in 2022, accused Masimo of infringing on two design patents to enhance its own smartwatch offerings. The jury found that Masimo’s discontinued Freedom and W1 smartwatches violated Apple’s patents, but current Masimo products were not found to infringe.

該訴訟由蘋果於 2022 年發起，指控 Masimo 侵犯兩項設計專利，以增強自己的智慧手錶產品。陪審團認定，Masimo 已停產的 Freedom 和 W1 智慧手錶侵犯了蘋果的專利，但目前的 Masimo 產品並未被發現侵權。

Apple’s legal team sought an injunction against Masimo’s current products, but this request was denied by the jury. Apple expressed satisfaction with the ruling, stating it protects their innovations.

蘋果的法律團隊尋求針對 Masimo 目前產品的禁令，但這項要求被陪審團拒絕。蘋果對裁決表示滿意，並稱其保護了他們的創新。

"We're pleased that the jury found Masimo infringed on our patents and awarded damages. This verdict underscores the importance of protecting our innovations, which ultimately benefit our users."

“我們很高興陪審團發現 Masimo 侵犯了我們的專利並判給我們賠償。這一裁決強調了保護我們創新的重要性，這最終使我們的用戶受益。”

Meanwhile, Masimo viewed the verdict as a victory, emphasizing that the infringement ruling applied only to outdated models.

同時，馬西莫認為該判決是一次勝利，並強調侵權判決僅適用於過時的型號。

"We are pleased that the jury found no infringement of Apple's patents by any Masimo products currently on the market and that the verdict relates solely to two older models of smartwatches that Masimo discontinued several years ago."

“我們很高興陪審團發現目前市場上的任何 Masimo 產品均未侵犯蘋果的專利，並且該判決僅涉及 Masimo 幾年前停產的兩款舊款智能手錶。”

See Also: Nvidia CEO Jensen Huang Meets Indian Billionaire Mukesh Ambani, Duo Forge Partnership To Build AI Infrastructure

另請參閱：Nvidia 首席執行官黃仁勳會見印度億萬富翁穆克什·安巴尼 (Mukesh Ambani)，Duo Forge 合作建立人工智慧基礎設施

The legal battle between Apple and Masimo has been ongoing, with Masimo previously accusing Apple of poaching its employees and copying its pulse oximetry technology.

蘋果和 Masimo 之間的法律鬥爭一直在持續，Masimo 先前指控蘋果挖走員工並抄襲其脈搏血氧儀技術。

Masimo had filed a countersuit against Apple, alleging that the company stole trade secrets related to pulse oximetry technology for its Apple Watch. A Delaware jury rejected Masimo's claims in that case last year.

Masimo 對蘋果公司提起反訴，指控該公司竊取了與 Apple Watch 脈搏血氧飽和度技術相關的商業機密。去年，特拉華州陪審團駁回了馬西莫在此案中的主張。

Both companies are engaged in the development and sale of smartwatches and other wearable devices, making their legal dispute a point of contention in the consumer tech space.

兩家公司都從事智慧手錶和其他穿戴式裝置的開發和銷售，這使得它們的法律糾紛成為消費科技領域的爭論焦點。

Why It Matters: Earlier this year, Apple managed to avoid an import ban on its latest Apple Watch models by redesigning the product, a move that temporarily safeguarded its sales in the U.S. market. However, this decision is not final and could be challenged by the U.S. International Trade Commission.

重要性：今年早些時候，蘋果透過重新設計產品，成功避免了對其最新 Apple Watch 的進口禁令，此舉暫時保障了其在美國市場的銷售。然而，這項決定並不是最終決定，可能會受到美國國際貿易委員會的質疑。

In response to the looming ban, Apple released versions of its watches without the blood oxygen feature, ensuring continued sales in the U.S.

為了應對迫在眉睫的禁令，蘋果發布了不含血氧功能的手錶版本，以確保在美國的持續銷售

This strategic adjustment highlights Apple’s adaptability in the face of legal challenges.

此次策略調整凸顯了蘋果面對法律挑戰的適應力。

Meanwhile, Masimo’s CEO Joe Kiani has publicly criticized the reliability of Apple's blood oxygen monitoring feature, underscoring the competitive tensions between the two firms.

同時，Masimo 的執行長 Joe Kiani 公開批評了蘋果血氧監測功能的可靠性，凸顯了兩家公司之間的競爭緊張關係。